Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Bladder Cancer

  Free Subscription

Articles published in Cancer

Retrieve available abstracts of 12 articles:
HTML format

Single Articles

    August 2022
  1. MARTINI A, Yu M, Raggi D, Joshi H, et al
    Adjuvant immunotherapy in patients with high-risk muscle-invasive urothelial carcinoma: The potential impact of informative censoring.
    Cancer. 2022;128:2892-2897.
    PubMed     Abstract available

    March 2022
  2. KOSHKIN VS, Henderson N, James M, Natesan D, et al
    Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
    Cancer. 2022;128:1194-1205.
    PubMed     Abstract available

    September 2021
  3. SMITH AB, Lee JR, Lawrence SO, Lavallee DC, et al
    Patient and public involvement in the design and conduct of a large, pragmatic observational trial to investigate recurrent, high-risk non-muscle-invasive bladder cancer.
    Cancer. 2021 Sep 8. doi: 10.1002/cncr.33897.
    PubMed     Abstract available

    July 2021
  4. LAWLER C, Gu L, Howard LE, Branche B, et al
    The impact of the social construct of race on outcomes among bacille Calmette-Guerin-treated patients with high-risk non-muscle-invasive bladder cancer in an equal-access setting.
    Cancer. 2021 Jul 8. doi: 10.1002/cncr.33792.
    PubMed     Abstract available

    May 2021
  5. HAEUSER L, Marchese M, Schrag D, Trinh QD, et al
    The impact of smoking on radical cystectomy complications increases in elderly patients.
    Cancer. 2021;127:1387-1394.
    PubMed     Abstract available

    March 2021
    Liquid biopsy test appears better at detecting bladder cancer than urine cytology.
    Cancer. 2021;127:663.

    January 2021
  7. LAUTZ TB, Chi YY, Li M, Wolden SL, et al
    Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.
    Cancer. 2021;127:275-283.
    PubMed     Abstract available

    November 2020
  8. GARG T, McMullen CK, Leo MC, O'Keeffe-Rosetti MC, et al
    Predicting risk of multiple levels of recurrence and progression after initial diagnosis of nonmuscle-invasive bladder cancer in a multisite, community-based cohort.
    Cancer. 2020 Nov 4. doi: 10.1002/cncr.33300.
    PubMed     Abstract available

    June 2020
  9. PAL SK, Bajorin D, Dizman N, Hoffman-Censits J, et al
    Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
    Cancer. 2020;126:2597-2606.
    PubMed     Abstract available

    January 2020
  10. O'DONNELL PH, Arkenau HT, Sridhar SS, Ong M, et al
    Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
    Cancer. 2020;126:432-443.
    PubMed     Abstract available

    October 2019
  11. FLETCHER SA, Cole AP, Lu C, Marchese M, et al
    The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years.
    Cancer. 2019 Oct 18. doi: 10.1002/cncr.32562.
    PubMed     Abstract available

    May 2019
  12. BERG S, D'Andrea D, Vetterlein MW, Cole AP, et al
    Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Cancer. 2019;125:1449-1458.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.